LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Hematological Parameters Predict Severity of Acute Pancreatitis

By LabMedica International staff writers
Posted on 23 Jul 2018
Image: A blood smear shows size heterogeneity of peripheral red blood cells, known as anisocytosis (Photo courtesy of Dr. Jay Park, MD).
Image: A blood smear shows size heterogeneity of peripheral red blood cells, known as anisocytosis (Photo courtesy of Dr. Jay Park, MD).
Acute pancreatitis (AP) is an acute inflammation of the pancreatic parenchyma induced by activated pancreatic enzymes due to multiple causes. Current severity scores include multiple variables and some of them are only complete within 48 hours of admission.

Until now, no single serum marker is able to predict severity or mortality in AP at admission. Red cell distribution width (RDW) is a routine parameter of the complete blood count test, described as simple, easy, inexpensive and quantitative that measures the size heterogeneity of peripheral red blood cell (RBC), known as anisocytosis.

Gastroenterologists at the University of Coimbra (Coimbra, Portugal) conducted a retrospective case-control study from January 2014 to December 2016, including a total of 312 consecutive admissions with AP. Ninety-one patients with severe AP were identified during the study period (cases) and were compared with patients with mild AP (controls), in the 1:1 proportion.

Biochemical and arterial blood gas (ABG) tests at admission were also registered, including white blood cells (WBC) count, aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin, platelet count, blood urea nitrogen (BUN), creatinine, international normalized ratio (INR), albumin, lactate dehydrogenase (LDH), serum glucose, hemoglobin, hematocrit, serum amylase, C-reactive protein at 0 hour (CRP0h), CRP at 24 hours (CRP24h), arterial lactate, arterial partial pressure of oxygen, D-dimers, total serum calcium (TSC), RDW at 0 hour (RDW0h), RDW at 24 hour (RDW24h). Additionally, RDW0h-to-TSC ratio and RDW0h-to-platelets ratio were evaluated.

The team found that there was a significant association of severe AP with high BUN (26.6 ± 17.1 versus 19.4 ± 8.8); serum glucose (168.0 ± 72.6 versus 130.9 ± 35.5); RDW0h (14.6 ± 1.3 versus 12.7 ± 0.5); RDW24h (14.3 ± 1.9 versus 12.8 ± 0.5); and RDW0h-to-TSC ratio (1.8 ± 0.4 versus 1.3 ± 0.1). The overall mortality rate was 8.8% (16/182), all cases associated with severe AP, corresponding to a mortality rate of 17.6% (16/91) in the severe AP group. Relatively to mortality in AP and as verified for AP severity, RDW at 0 hours and 24 hours post-admission were the best predictors for mortality in AP, followed by RDW0h-to-TSC ratio.

The authors concluded that RDW is a simple routine parameter, available at admission. The AP cohort showed that RDW0h of greater than 13.0 and RDW0h-to-total serum calcium ratio greater than 1.4 were excellent predictors for severity and RDW0h greater than 14.0 and RDW0h-to-total serum calcium ratio of greater than 1.7 were very-good predictors for mortality, being superior to conventional prognostic scoring systems. The study was published on July 5, 2018, in the journal BMC Gastroenterology.

Related Links:
University of Coimbra

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more